Inratio is a medical device brand that specializes in portable coagulation monitoring systems. Their products are designed to measure and monitor blood clotting levels in patients.
Inratio was established in 1999.
The company is headquartered in Princeton, New Jersey.
Inratio is a subsidiary of Alere Inc., which is now part of Abbott Laboratories.
The brand focuses on developing easy-to-use, handheld coagulation monitoring devices.
Inratio devices have been used in various clinical settings to help manage patients' anticoagulation therapy.
The brand has received regulatory approvals from FDA and other global health authorities.
Inratio has a strong commitment to patient safety and innovation in coagulation monitoring technology.
Roche Diagnostics is one of the leading providers of coagulation monitoring systems. They offer a range of devices for laboratory and point-of-care testing.
Siemens Healthineers is a global medical technology company. They provide a variety of coagulation monitoring systems for both laboratory and point-of-care settings.
Stago is renowned for its hemostasis diagnostic products and offers a comprehensive range of coagulation testing systems for clinical laboratories.
This is a handheld, portable coagulation monitoring system that provides fast and accurate results for PT/INR testing. It is used to monitor patients on warfarin therapy.
This is an enhanced version of the Inratio PT/INR System, offering additional features and improved usability.
Inratio devices are designed to measure and monitor blood clotting levels in patients, specifically PT/INR values. They assist in the management of anticoagulation therapy.
Yes, Inratio devices are designed to be user-friendly and portable. They provide fast and accurate results, allowing for convenient coagulation monitoring.
Yes, Inratio devices are suitable for home use. They allow patients to test their PT/INR levels in the comfort of their own homes, reducing the need for frequent visits to healthcare facilities.
Yes, Inratio devices have received regulatory clearances and approvals from FDA and other global health authorities, ensuring their safety and efficacy.
Absolutely. Inratio devices have been widely used in clinical settings, such as hospitals, clinics, and healthcare facilities, to monitor and manage anticoagulation therapy.